Dr. Fabrizio Pane, MD
Claim this profileAzienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia
Studies Leukemia
Studies Relapse
16 reported clinical trials
22 drugs studied
Area of expertise
1Leukemia
2Relapse
FLT3 positive
D835 positive
Stage II
Clinical Trials Fabrizio Pane, MD is currently running
Tazemetostat + Lenalidomide + Rituximab
for Follicular Lymphoma
The participants of this study would have relapsed/refractory follicular lymphoma. Follicular lymphoma is a type of blood cancer. It is referred to as 'relapsed' when the disease has come back after a period of improvement after that follows a treatment regimen and 'refractory' when treatment no longer works. Stage 1 of this trial will study the safety and the level that adverse effects of each of the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for stage 2 and 3. Stage 1 of the study is completed. Stages 2 and 3 will evaluate and compare how long participants live without their disease getting worse when receiving the study drug in combination with other drug treatment versus the placebo (dummy drug) in combination with other drug treatment.
Recruiting1 award Phase 34 criteria
Depemokimab
for Hypereosinophilic Syndrome
This trial is testing a new medication called depemokimab for adults with Hypereosinophilic Syndrome (HES) who are not responding well to their current treatments. The medication aims to lower the number of certain white blood cells that cause symptoms to worsen. Participants will either receive depemokimab or continue their usual treatment.
Recruiting1 award Phase 35 criteria
More about Fabrizio Pane, MD
Clinical Trial Related8 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Fabrizio Pane, MD has experience with
- Placebo
- Rituximab
- Lenalidomide
- Dasatinib
- Crenolanib
- Luspatercept
Breakdown of trials Fabrizio Pane, MD has run
Leukemia
Relapse
Acute Myeloid Leukemia
Anemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Fabrizio Pane, MD specialize in?
Fabrizio Pane, MD focuses on Leukemia and Relapse. In particular, much of their work with Leukemia has involved treating patients, or patients who are undergoing treatment.
Is Fabrizio Pane, MD currently recruiting for clinical trials?
Yes, Fabrizio Pane, MD is currently recruiting for 2 clinical trials in Napoli Campania. If you're interested in participating, you should apply.
Are there any treatments that Fabrizio Pane, MD has studied deeply?
Yes, Fabrizio Pane, MD has studied treatments such as Placebo, Rituximab, Lenalidomide.
What is the best way to schedule an appointment with Fabrizio Pane, MD?
Apply for one of the trials that Fabrizio Pane, MD is conducting.
What is the office address of Fabrizio Pane, MD?
The office of Fabrizio Pane, MD is located at: AOU Federico II, Napoli, Campania 80122 Italy. This is the address for their practice at the AOU Federico II.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.